(CNN) — People looking to lose weight and lower their blood sugar may someday be able to get a single injection that turns their cells into tiny factories churning out a protein that is essentially the active ingredient in drugs like Ozempic, Wegovy, Zepbound and Mounjaro.
That’s the ambition of two biotech startups, New York-based RenBio and Fractyl Health in Massachusetts. Both companies have completed initial tests showing that their approaches work, at least in mice, and both have started tests in larger animals — pigs and monkeys — to see whether their gene therapies can work in larger animals.
With continued success and enough funding, they hope to bring the therapies to human patients — although it may take years more research to prove that their ideas work and are safe.
Newer G

KTBS Health

Newsweek Top
Raw Story
Associated Press US and World News Video
New Hampshire Union Leader
People Human Interest
People Top Story
OK Magazine
The Conversation
ABC News
The List